We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00506519
Recruitment Status : Terminated
First Posted : July 25, 2007
Last Update Posted : August 24, 2010
Information provided by:
LEO Pharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Study Completion Date : March 2009